| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| efsa peer review diflufenican | 0.28 | 0.2 | 4161 | 59 | 29 |
| efsa | 0.89 | 0.3 | 7958 | 80 | 4 |
| peer | 0.63 | 0.1 | 7721 | 72 | 4 |
| review | 1.52 | 1 | 3902 | 4 | 6 |
| diflufenican | 0.82 | 0.5 | 5711 | 26 | 12 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| efsa peer review diflufenican | 0.51 | 0.1 | 171 | 40 |
| saflufenacil efsa peer review | 1.4 | 0.7 | 7201 | 63 |
| efsa peer review flonicamid | 0.16 | 0.6 | 7586 | 72 |
| efsa peer review fenpropidin | 1.28 | 0.4 | 7930 | 17 |
| efsa conclusion on the peer review | 0.05 | 0.4 | 4223 | 98 |
| efsa peer review cyazofamid | 1.38 | 0.3 | 2293 | 43 |
| efsa peer review acequinocyl | 0.18 | 0.5 | 8097 | 100 |
| efsa peer review azoxystrobin | 1.47 | 0.4 | 4641 | 68 |
EFSA no longer uses the DAR (Draft Assessment Reports) application tool. Since October 2019, all old DARs and addenda have been migrated to the EFSA website, removing the need for users to register by providing their personal data.
Is EFA comments will be published?are related to policy or risk management aspects, which is out of the scope of EFSA's activity. EFSA will assess all comments from interested parties, which are submitted in line with the criteria above. All submitted comments will be published. This website needs some cookies and similar means to function.
Is diflufenican toxic to mammals?Concerning the mammalian toxicology assessment, diflufenican has a low acute toxicity, is not irritant and has no skin sensitisation potential. In repeat dose studies, the main adverse effects were on the body weight gain and in the liver.
